These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4283703)

  • 1. Antagonism of acute amphetamine intoxication by haloperidol and propranolol.
    Davis WM; Logston DG; Hickenbottom JP
    Toxicol Appl Pharmacol; 1974 Sep; 29(3):397-403. PubMed ID: 4283703
    [No Abstract]   [Full Text] [Related]  

  • 2. Antagonism of cocaine, amphetamine, and methamphetamine toxicity.
    Derlet RW; Albertson TE; Rice P
    Pharmacol Biochem Behav; 1990 Aug; 36(4):745-9. PubMed ID: 2217500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine: possible site and mode of action for producing anorexia in the rat.
    Leibowitz SF
    Brain Res; 1975 Jan; 84(1):160-7. PubMed ID: 1053933
    [No Abstract]   [Full Text] [Related]  

  • 4. Further studies on the antagonism of stereotyped behaviour induced by amphetamine.
    Del Rio J; Fuentes JA
    Eur J Pharmacol; 1969 Oct; 8(1):73-8. PubMed ID: 4391046
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of d,1-propranolol and haloperidol on aggressive behavior induced in mice by isolation and isolation plus amphetamine treatment.
    Poli A; Palermo-Neto J
    Braz J Med Biol Res; 1986; 19(3):411-7. PubMed ID: 3594007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antagonism of AP-5- and amphetamine-induced behaviour by timelotem as compared with clozapine and haloperidol.
    Schmidt WJ; Krähling H; Ruhland M
    Life Sci; 1987 Oct; 41(16):1909-14. PubMed ID: 2889124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-lasting reduction of amphetamine-induced hyperactivity in rats after combined administration of caerulein with haloperidol.
    Matsubara K; Matsushita A
    Eur J Pharmacol; 1984 May; 101(1-2):157-8. PubMed ID: 6745317
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of d,l-propranolol on open field behavior of rats.
    Poli A; Palermo-Neto J
    Psychopharmacology (Berl); 1985; 86(1-2):153-5. PubMed ID: 3927351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol.
    Megens AA; Niemegeers CJ; Awouters FH
    J Pharmacol Exp Ther; 1992 Jan; 260(1):160-7. PubMed ID: 1370539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against d-amphetamine toxicity.
    Derlet RW; Albertson TE; Rice P
    Am J Emerg Med; 1990 Mar; 8(2):105-8. PubMed ID: 2302276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.
    Warburton EC; Joseph MH; Feldon J; Weiner I; Gray JA
    Psychopharmacology (Berl); 1994 May; 114(4):657-64. PubMed ID: 7855229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascorbate antagonizes the behavioral effects of amphetamine by a central mechanism.
    White LK; Carpenter M; Block M; Basse-Tomusk A; Gardiner TW; Rebec GV
    Psychopharmacology (Berl); 1988; 94(2):284-7. PubMed ID: 2832869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Endorphin involvement in the antidopaminergic effect of caerulein.
    Matsubara K; Matsushita A
    Jpn J Pharmacol; 1986 Mar; 40(3):417-22. PubMed ID: 2940395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of catecholaminergic receptor blockers with lethal doses of amphetamine or substituted amphetamines in mice.
    Davis WM; Hatoum HT; Waters IW
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):27-36. PubMed ID: 687391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of play fighting by amphetamine: effects of catecholamine antagonists, agonists and synthesis inhibitors.
    Beatty WW; Costello KB; Berry SL
    Pharmacol Biochem Behav; 1984 May; 20(5):747-55. PubMed ID: 6539920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of both opiate and catecholaminergic receptors in the behavioural excitation provoked by thyrotropin-releasing hormone: comparisons with amphetamine.
    Lin MT; Chan HK; Chen CF; Teh GW
    Neuropharmacology; 1983 Apr; 22(4):463-9. PubMed ID: 6304565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of propranolol, nalorphine and haloperidol on the breathing and on the metabolism of PGI2 and TXA2 of normotensive and spontaneously hypertensive rats.
    Barát E; Huszár E; Vértes K; Debreczeni LA
    Acta Physiol Hung; 1989; 74(1):37-41. PubMed ID: 2515749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine stimulation of glutaminase is blocked by neuroleptics.
    Sherman AD; Mott J
    Life Sci; 1985 Mar; 36(12):1163-7. PubMed ID: 2580205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of caerulein + haloperidol on amphetamine-induced locomotor stereotypy in rats.
    Mueller K; Peel JL; Rewey KL
    Life Sci; 1989; 44(11):717-24. PubMed ID: 2927242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of catecholaminergic blockade by haloperidol or propranolol at different stages of the oestrous cycle on ovulation and gonadotrophin levels in the rat.
    Domínguez R; Gaitán CM; Méndez SA; Ulloa-Aguirre A
    J Endocrinol; 1987 Apr; 113(1):37-44. PubMed ID: 3108438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.